eye disease: A non-neoplastic or neoplastic disorder that affects the eye. Representative examples include conjunctivitis, glaucoma, cataract, conjunctival squamous cell carcinoma, uveal melanoma, and retinoblastoma. [NCIt:C26767]
Postprocedural disorders of ear and mastoid process, not elsewhere classified
DOID EFO Endpoint Browser PheWeb
H8_POSTOP
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
288 |
6. Filter based on genotype QC (FinnGen only) |
288 |
Control definitions (FinnGen only)
- Control exclude
- H8_OTHEREAR
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Postprocedural disorders of ear and mastoid process, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Other disorders of ear
- Diseases of the ear and mastoid process
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2836 | 1357 | 1468 |
| Only index persons | 2677 | 1286 | 1391 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.04 |
| Only index persons | 0.05 | 0.05 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 61.03 | 64.13 | 58.11 |
| Only index persons | 60.48 | 63.48 | 57.72 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 288 | 143 | 145 |
| Unadjusted period prevalence (%) | 0.06 | 0.05 | 0.06 |
| Median age at first event (years) | 61.46 | 60.77 | 62.15 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 260
- Matched controls
- 2598
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H71
ICD-10 Finland
Cholesteatoma of middle ear
1097.8
164.4
144
*
UDC00
NOMESCO Finland
Ear microscopy
78.4
141.7
158
50
H95.1
ICD-10 Finland
Other disorders following mastoidectomy
+∞
136.9
119
*
H95.0
ICD-10 Finland
Recurrent cholesteatoma of postmastoidectomy cavity
+∞
119.1
105
*
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
90.8
83.4
90
15
H95.8
ICD-10 Finland
Other postprocedural disorders of ear and mastoid process
+∞
74.6
68
*
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
+∞
60.8
56
*
DFF00
NOMESCO Finland
Pure tone audiometry
31.9
51.9
69
29
Z01.1
ICD-10 Finland
Examination of ears and hearing
13.9
49.3
91
97
38700
ICD-8 Finland
Other disease of ear and mastoid process, Cholesteatoma of ear
+∞
47.3
44
*
3853A
ICD-9 Finland
Other disorders of middle ear and mastoid, Cholesteatoma of middle ear and mastoid
438.2
39.1
38
*
38110
ICD-8 Finland
Otitis media without mention of mastoiditis, Chronic
214.5
36.8
37
*
Z97.4
ICD-10 Finland
Presence of external hearing-aid
53.7
34.9
41
9
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
29.1
34.1
46
19
H66.4
ICD-10 Finland
Suppurative otitis media, unspecified
85.6
33.8
37
5
H66.3
ICD-10 Finland
Other chronic suppurative otitis media
194.5
33.6
34
*
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
46.8
33.2
40
10
H66.9
ICD-10 Finland
Otitis media, unspecified
15.9
31.9
53
41
H65.3
ICD-10 Finland
Chronic mucoid otitis media
49.1
31.9
38
9
H66.0
ICD-10 Finland
Acute suppurative otitis media
14.8
29.3
50
41
DEB25
NOMESCO Finland
Attico-antro-mastoidectomy and tympanoplasty
+∞
28.7
27
*
DEA10
NOMESCO Finland
Attico-antrotomy
+∞
28.7
27
*
DBD20
NOMESCO Finland
Plastic repair of external auditory canal
313.2
28.3
28
*
DEB30
NOMESCO Finland
Radical mastoidectomy
+∞
27.6
26
*
H70.1
ICD-10 Finland
Chronic mastoiditis
+∞
26.5
25
*
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
+∞
26.5
25
*
38210
ICD-8 Finland
Chronic otitis media with mastoiditis
100.0
25.2
27
*
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
275.2
25.1
25
*
DAX08
NOMESCO Finland
Fitting of hearing aid
62.3
24.6
28
5
DCD00
NOMESCO Finland
Myringoplasty
91.8
23.1
25
*
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
68.7
22.3
25
*
TDA90
NOMESCO Finland
Removal wax from ear
65.7
21.3
24
*
4147
FHL
Radical surgery, cavity filling and middle ear and / or eardrum plastic
+∞
21.1
20
*
Z97.8
ICD-10 Finland
Presence of other specified devices
+∞
21.1
20
*
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
119.6
20.9
22
*
H72.2
ICD-10 Finland
Other marginal perforations of tympanic membrane
227.3
20.9
21
*
H74.1
ICD-10 Finland
Adhesive middle ear disease
227.3
20.9
21
*
S02CA02
ATC
flumetasone and antiinfectives; otic
9.1
20.3
44
57
H95.9
ICD-10 Finland
Postprocedural disorder of ear and mastoid process, unspecified
+∞
20.0
19
*
DCD10
NOMESCO Finland
Tympanoplasty
113.7
19.9
21
*
DFF15
NOMESCO Finland
Speech audiometry
20.2
19.6
29
16
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
15.1
18.8
31
23
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
19.4
18.7
28
16
DC1AD
NOMESCO Finland
Temporalbone CT
71.8
18.0
20
*
WX704
NOMESCO Finland
Intubation
6.1
17.5
50
97
DEB20
NOMESCO Finland
Attico-antro-mastoidectomy and tympanotomy
181.0
16.7
17
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
5.1
16.7
56
132
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
+∞
15.8
15
*
H65.4
ICD-10 Finland
Other chronic nonsuppurative otitis media
+∞
15.8
15
*
H60.9
ICD-10 Finland
Otitis externa, unspecified
7.1
15.3
38
61
3821A
ICD-9 Finland
Suppurative and unspecified otitis media, Chronic tubotympanic suppurative otitis media
147.3
13.6
14
*
WX720
NOMESCO Finland
Own respiration
7.5
13.1
31
46
Z98.8
ICD-10 Finland
Other specified postsurgical states
20.4
13.1
19
10
H65.2
ICD-10 Finland
Chronic serous otitis media
24.0
13.1
18
8
4151
FHL
Reoperation for chronic otitis media
+∞
12.6
12
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.6
12.4
147
867
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
19.2
12.2
18
10
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
20.1
11.7
17
9
H72.9
ICD-10 Finland
Perforation of tympanic membrane, unspecified
68.1
11.7
13
*
H74.2
ICD-10 Finland
Discontinuity and dislocation of ear ossicles
125.2
11.5
12
*
WX725
NOMESCO Finland
Noninvasive ventilation
6.1
11.5
31
56
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
18.1
11.3
17
10
H60.4
ICD-10 Finland
Cholesteatoma of external ear
45.3
11.0
13
*
H69.0
ICD-10 Finland
Patulous Eustachian tube
62.6
10.7
12
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
5.3
10.5
32
67
Z01.8
ICD-10 Finland
Other specified special examinations
2.8
10.4
76
330
H92.0
ICD-10 Finland
Otalgia
7.8
10.2
23
32
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
9.7
10.2
20
22
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.6
10.2
89
431
WX702
NOMESCO Finland
Supraglottic ventilation device
5.8
9.7
27
51
ZZG00
NOMESCO Finland
Graft of cartilage
103.6
9.5
10
*
H93.1
ICD-10 Finland
Tinnitus
10.1
9.4
18
19
4150
FHL
Tympanoplasty (including for reasons other than inflammation)
+∞
9.4
9
*
DGW00
NOMESCO Finland
Dilatation of eustachian tube
+∞
9.4
9
*
H60.3
ICD-10 Finland
Other infective otitis externa
10.6
9.2
17
17
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.9
9.0
61
251
H73.1
ICD-10 Finland
Chronic myringitis
92.9
8.5
9
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
8.4
58
241
H90.8
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unspecified
+∞
8.4
8
*
H66.2
ICD-10 Finland
Chronic atticoantral suppurative otitis media
+∞
8.4
8
*
J01DA09
ATC
[U] cefadroxil; inhalant, oral
2.4
8.4
83
424
H60.8
ICD-10 Finland
Other otitis externa
8.9
7.9
16
19
H72.1
ICD-10 Finland
Attic perforation of tympanic membrane
82.3
7.5
8
*
DEB10
NOMESCO Finland
Attico-antro-mastoidectomy
82.3
7.5
8
*
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
82.3
7.5
8
*
Z3229
NOMESCO Finland
Other healthcare associate professional
3.9
7.4
29
80
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
6.9
7.2
17
26
H91.1
ICD-10 Finland
Presbycusis
6.9
7.2
17
26
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.1
7.1
106
644
J01DA06
ATC
[U] cefuroxime; systemic
2.8
7.0
45
179
SPAT1301
SPAT
No procedures
2.1
6.6
97
582
R5120
NOMESCO Finland
Preparation of an aid
10.4
6.6
12
12
J01DA01
ATC
[U] cefalexin; systemic
2.0
6.5
161
1176
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
5.8
6.4
17
31
38401
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) chronica adhaesiva
+∞
6.3
6
*
DED00
NOMESCO Finland
Obliteration of cavity after partial excision of mastoid
+∞
6.3
6
*
J01MA02
ATC
ciprofloxacin; systemic
2.0
6.3
114
740
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
6.1
65
337
H65.0
ICD-10 Finland
Acute serous otitis media
10.4
6.1
11
11
SPAT1097
SPAT
Recording of ECG
2.4
6.1
52
242
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
86
255
4.38
26.78
2.3
1.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
47
140
3.82
13.99
6.7
8.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
53
196
3.09
11.16
4.2
4.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
63
269
2.72
10.16
1.7
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
62
312
2.26
6.86
5.8
7.3
mmol/l
2.5
1.3
1.71
47
244
(3021589) Normoblasts [#/volume] in Blood
54
983
0.45
6.79
8.4
9.5
e9/l
0.0
0.0
1.48
45
813
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
84
486
2.03
6.46
5.5
4.0
ng/l
23.1
283.3
2.56
75
399
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
61
313
2.20
6.41
5.7
7.2
kpa
5.0
5.1
0.44
56
300
(3005570) Glucose [Moles/volume] in Urine
10
17
6.06
5.66
2.0
2.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
55
288
2.12
5.45
2.4
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
55
296
2.06
5.06
2.2
1.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
62
3.21
4.89
2.1
2.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
178
2130
0.57
4.87
13.6
14.8
ml/min/173m2
77.0
77.4
0.07
134
1760
(3009508) Creatinine [Moles/volume] in Urine
104
701
1.76
4.78
4.0
3.2
mmol/l
7.2
7.3
0.06
91
586
(3032080) INR in Blood by Coagulation assay
137
1011
1.68
4.44
11.3
10.3
inr
1.5
1.3
0.54
30
288
(3042936) Bacteria identified in Isolate by Culture
58
335
1.92
4.35
2.4
1.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
67
411
1.82
4.16
2.4
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
229
1960
1.82
4.10
23.2
17.4
%
39.8
39.8
0.05
123
1324
(3020682) Albumin/Creatinine [Ratio] in Urine
101
723
1.61
3.51
3.3
4.1
mg/mmol
10.7
12.2
0.12
53
457
(3026389) Candida sp identified in Specimen by Organism specific culture
9
18
5.12
3.40
1.2
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
95
683
1.58
3.19
3.0
3.3
mg/l
49.2
224.2
0.93
49
458
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
20
86
2.42
3.16
3.5
2.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
45
708
0.57
3.07
3.7
3.2
e6/l
0.5
0.4
0.09
36
532
(3017704) Immunofixation for Urine
9
21
4.39
3.02
1.2
1.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
51
771
0.59
2.98
3.5
3.2
e6/l
15.6
73.0
2.47
43
596
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
23
113
2.13
2.70
2.7
2.4
—
—
—
0
0
(44790047)
9
24
3.84
2.69
1.4
1.4
—
—
—
0
0
(44790049)
9
24
3.84
2.69
1.4
1.4
—
—
—
0
0
(44806118)
9
24
3.84
2.69
1.4
1.4
—
—
—
0
0
(44790048)
9
24
3.84
2.69
1.4
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
8
210
0.36
2.67
2.5
3.1
mmol/l
1.2
1.2
—
8
184
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
97
726
1.51
2.65
3.0
2.4
u/l
48.1
55.8
1.91
92
675
(3003338) MCHC [Mass/volume]
211
1845
1.54
2.65
26.9
20.9
g/l
332.3
331.7
0.47
211
1832
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
83
602
1.53
2.62
1.7
1.7
mmol/l
1.4
1.3
0.37
75
504
(36304419) Bacteria [Presence] in Urine
46
690
0.60
2.55
3.4
3.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
8
205
0.37
2.54
7.0
3.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
31
515
0.55
2.52
3.1
3.0
ug/l
0.7
0.8
0.27
20
351
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
233
2093
1.59
2.49
4.6
4.6
mu/l
2.1
1.9
0.78
213
1862
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
196
1699
1.48
2.47
3.6
3.8
pmol/l
14.8
14.9
0.31
183
1507
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
66
905
0.65
2.45
3.7
3.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
32
184
1.83
2.44
2.1
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
187
1609
1.46
2.42
6.0
4.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29
485
0.55
2.41
2.6
2.8
mmol/l
2.5
2.5
0.35
21
431
(1761868) Lipid panel - Serum or Plasma
47
689
0.62
2.35
2.9
3.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
38
586
0.60
2.34
3.9
3.9
%
90.0
87.7
0.24
38
576
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
147
1215
1.43
2.33
7.0
6.8
mmol/l
1.2
1.2
0.28
132
1016
(3013826) Glucose [Moles/volume] in Serum or Plasma
165
1394
1.43
2.31
5.1
4.7
mmol/l
6.9
6.7
0.35
151
1316
(3019150) Specific gravity of Urine by Refractometry
71
513
1.51
2.26
4.7
4.1
kg/l
1.0
1.0
0.14
21
78
(3024980) IgG subclass 4 [Mass/volume] in Serum
10
36
2.84
2.22
1.0
1.3
g/l
0.3
0.7
—
5
31
(40761511) CBC panel - Blood by Automated count
252
2331
1.65
2.10
21.5
14.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
66
882
0.67
2.10
3.4
3.8
e6/l
23.3
167.4
1.17
45
632
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
239
2185
1.55
2.09
5.0
4.8
mmol/l
6.0
6.0
0.39
228
1960
(3023368) Bacteria identified in Blood by Culture
91
702
1.43
2.06
4.4
4.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
164
1402
1.39
2.05
3.5
2.9
u/l
59.4
51.0
0.43
149
1303
(3044640) Blood type and Crossmatch panel - Blood
53
735
0.66
2.02
2.5
2.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
21
3.39
1.97
1.1
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
34
213
1.68
1.96
1.7
1.6
—
—
—
0
0
(4035726)
10
223
0.43
1.94
1.5
1.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
135
1125
1.38
1.93
5.2
5.7
mmol/l
1.2
1.2
0.19
123
1016
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
14
274
0.49
1.92
2.2
3.5
—
—
—
0
0
(3026782) Osmolality of Urine
34
514
0.62
1.91
3.1
2.9
mosm/kgh2o
498.2
557.9
0.91
27
433
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
25
399
0.59
1.75
2.9
3.1
e6/l
2.3
2.4
0.03
18
218
(3022145) Colonoscopy Study observation
13
251
0.50
1.72
1.0
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
13
3.89
1.72
1.6
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
13
3.89
1.72
1.6
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
28
422
0.63
1.55
1.3
1.4
g/l
2.6
2.4
0.18
17
246
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
69
532
1.39
1.54
1.5
1.8
pmol/l
232258439.8
12984475.8
0.73
62
439
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
118
990
1.33
1.53
2.1
2.0
pmol/l
89.7
93.6
0.46
65
504
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
27
2.63
1.52
1.4
1.3
—
—
—
0
0
(4062490)
6
21
2.90
1.51
1.0
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
21
2.90
1.51
1.2
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
229
2116
1.40
1.51
6.1
6.1
mmol/mol
40.2
40.4
0.10
214
1948
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
40
551
0.68
1.45
2.6
2.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
124
1054
1.31
1.45
5.8
4.4
g/l
34.2
35.1
0.97
111
993
(3004716) Salmonella sp identified in Stool by Organism specific culture
5
121
0.40
1.41
1.6
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
43
581
0.69
1.40
4.6
6.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
11
208
0.51
1.39
9.8
8.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
9
44
2.08
1.28
1.4
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
49
634
0.73
1.23
6.2
4.1
estimate
0.0
0.0
—
6
209
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
30
423
0.68
1.23
2.6
2.9
e6/l
0.7
0.9
0.47
23
238
(3031040) Bacteria [#/volume] in Urine by Automated count
175
1578
1.28
1.22
5.7
4.6
—
3935.8
—
0
30
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
33
0.00
1.17
0.0
2.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
42
552
0.72
1.16
2.5
2.5
e6/l
3.8
4.9
0.64
35
489
(3044927) Protein electrophoresis panel - Urine
0
35
0.00
1.16
0.0
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
20
2.53
1.15
2.0
2.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
183
1670
1.26
1.11
5.0
4.1
mm/h
15.0
13.3
0.72
172
1510
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
108
931
1.26
1.07
3.3
4.0
ng/l
122.6
39.7
0.39
72
706
(3015377) Calcium [Moles/volume] in Serum or Plasma
70
841
0.78
1.03
2.6
3.4
mmol/l
2.3
2.3
0.03
60
742
(3019309) Folate [Moles/volume] in Red Blood Cells
61
491
1.31
1.03
1.7
1.8
nmol/l
1003.6
1224.0
1.51
50
370
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
53
1.92
1.02
1.2
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
251
2395
1.37
1.01
11.4
10.6
u/l
24.5
25.0
0.25
241
2303
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
35
2.02
1.00
1.6
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
99
1137
0.80
0.99
5.8
5.1
estimate
0.0
0.0
—
6
217
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
38
288
1.37
0.96
1.1
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
51
1.79
0.95
1.4
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
88
750
1.25
0.95
4.4
5.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
91
779
1.25
0.94
4.5
3.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
27
2.25
0.94
2.8
2.8
nmol/l
33.8
3.4
—
6
27
(3013512) EKG study
59
714
0.78
0.92
4.3
4.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
102
0.48
0.91
1.0
2.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
89
763
1.24
0.91
3.2
3.6
ph
7.4
7.4
—
6
145
(3014111) Lactate [Moles/volume] in Serum or Plasma
14
212
0.64
0.83
7.9
7.0
mmol/l
1.4
1.4
0.04
14
203
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
90
782
1.22
0.80
3.3
3.2
ng/l
1533.3
1389.4
0.12
76
668
(3041096) Erythrocytes [Presence] in Urine by Automated
52
628
0.79
0.79
4.1
3.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
77
890
0.82
0.79
2.4
2.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
11
173
0.62
0.78
1.2
2.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
13
83
1.59
0.76
1.1
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
53
1.72
0.76
1.4
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
8
132
0.59
0.75
1.4
1.3
—
35.3
—
0
10
(36660697) Celiac disease serology panel - Serum
22
159
1.42
0.75
1.4
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
40
1.77
0.72
1.6
2.7
%
66.6
63.9
—
7
40
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
41
1.72
0.70
1.6
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
23
305
0.73
0.70
1.3
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
104
1157
0.84
0.70
4.6
3.8
estimate
0.0
0.0
—
7
213
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
26
338
0.75
0.70
1.4
1.3
u/ml
1.6
11.4
—
5
123
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
136
1247
1.17
0.65
3.0
2.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
228
2184
1.21
0.63
4.7
4.5
mmol/l
4.5
4.5
0.07
211
1983
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
234
2249
1.22
0.61
5.4
5.1
mmol/l
2.6
2.6
0.18
215
2025
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(4281824)
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
7
115
0.60
0.59
2.9
4.0
mmol/l
23.6
24.0
—
7
108
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
39
469
0.81
0.58
1.4
1.2
u/ml
4.2
1.6
—
9
116
(21494434) Karyotype in Bone marrow
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
40
477
0.81
0.56
5.6
4.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
234
2256
1.20
0.55
20.0
15.6
mg/l
24.5
25.2
0.12
198
1818
(3037756) Immunofixation for Serum or Plasma
9
60
1.52
0.55
1.6
2.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
39
1.55
0.53
1.7
2.6
—
—
—
0
0
(3044889) 12 lead EKG panel
170
1602
1.15
0.53
4.7
4.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
9
133
0.67
0.53
4.3
7.2
mmol/l
24.1
24.9
—
9
133
(3026493) Urate [Moles/volume] in Serum or Plasma
66
581
1.18
0.51
2.3
2.7
umol/l
372.3
6361.9
2.18
59
491
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
65
1.40
0.51
1.8
1.7
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
14
189
0.73
0.50
2.3
2.9
kpa
4.5
4.5
0.04
14
178
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
29
352
0.80
0.48
1.4
1.3
iu/ml
17.8
37.2
1.47
13
114
(3013650) Neutrophils [#/volume] in Blood by Automated count
123
1317
0.88
0.45
8.5
9.1
e9/l
4.4
4.2
0.47
115
1157
(4010399)
22
175
1.28
0.45
1.6
1.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
187
1786
1.13
0.44
8.0
7.5
u/l
83.3
78.6
0.47
178
1670
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
115
1067
1.13
0.43
5.3
4.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
57
1.41
0.42
1.0
1.1
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
5
33
1.52
0.41
1.6
1.9
u/ml
8.8
115.6
—
5
33
(3023511) Choriogonadotropin [Units/volume] in Urine
5
33
1.52
0.41
1.2
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
17
0.00
0.41
0.0
1.9
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
27
224
1.23
0.40
3.4
3.0
e9/l
77.9
68.3
0.70
21
176
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
55
488
1.16
0.40
1.7
1.8
mg/l
1.8
1.4
0.37
41
380
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
12
159
0.74
0.39
2.0
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
36
1.40
0.38
1.2
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
25
299
0.82
0.38
1.4
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
34
292
1.19
0.36
4.3
4.7
%
30.7
31.9
0.38
21
178
(4034850)
10
73
1.38
0.35
6.1
12.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
44
1.37
0.34
1.2
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
223
2168
1.13
0.34
4.6
4.5
mmol/l
1.4
1.5
1.38
206
1951
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
87
0.68
0.33
1.7
1.8
—
—
—
0
0
(3000492) Spirometry study
16
197
0.80
0.32
1.7
1.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
7
52
1.35
0.31
2.9
3.0
nmol/l
0.7
1.0
—
7
40
(3003694) ABO and Rh group [Type] in Blood
52
572
0.89
0.29
1.2
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
62
1.30
0.28
1.3
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
9
118
0.76
0.28
2.8
3.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
100
942
1.09
0.28
2.1
2.2
nmol/l
81.6
76.7
1.03
92
816
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
64
1.26
0.27
1.1
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
13
160
0.80
0.26
1.5
1.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
71
0.70
0.26
3.6
3.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
72
1.26
0.26
1.4
1.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
147
0.81
0.24
1.4
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
10
125
0.79
0.23
1.5
1.3
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
5
40
1.25
0.22
1.4
1.1
nmol/l
0.9
0.9
—
5
32
(3002256) Pathology report gross observation
25
283
0.87
0.22
1.4
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
42
1.19
0.21
1.8
1.4
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
117.8
—
0
11
(3036670) Protein [Mass/volume] in Synovial fluid
0
11
0.00
0.21
0.0
1.1
—
38.6
—
0
6
(3012565) Volume of 24 hour Urine
0
11
0.00
0.21
0.0
2.3
—
2246.8
—
0
11
(3037556) Urate [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
11.6
—
1363.3
—
0
10
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
10
0.00
0.21
0.0
9.7
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
10
0.00
0.21
0.0
6.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
8.7
—
784.3
—
0
10
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
5.2
—
0
12
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.3
—
898.2
—
0
12
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
4.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
20
229
0.86
0.21
2.3
4.0
kpa
5.5
5.8
0.79
20
220
(3022217) INR in Platelet poor plasma by Coagulation assay
33
364
0.89
0.20
40.0
23.5
—
1.3
—
0
48
(3000330) Specific gravity of Urine by Test strip
9
114
0.78
0.20
5.3
4.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
118
1133
1.07
0.20
5.3
5.8
e9/l
0.2
0.2
0.06
109
991
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
36
328
1.11
0.19
2.2
2.4
%
21.9
22.3
0.04
14
285
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
52
1.16
0.19
1.2
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
7
60
1.17
0.18
2.0
2.6
umol/l
30.6
35.1
—
7
52
(3022313) Gas panel - Capillary blood
13
110
1.19
0.17
1.8
4.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
13
152
0.85
0.17
1.5
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
66
0.75
0.17
1.2
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
140
0.85
0.15
1.7
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
12
140
0.85
0.15
1.1
1.2
iu/ml
27.5
158.3
—
7
50
(3043409) Potassium [Moles/volume] in Arterial blood
7
88
0.79
0.14
3.1
4.2
mmol/l
4.0
3.9
—
7
79
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
60
632
0.94
0.14
2.3
2.0
mg/l
2.3
3.2
3.13
53
534
(3020630) Protein [Mass/volume] in Serum or Plasma
19
212
0.89
0.14
1.3
2.5
g/l
62.5
66.3
1.22
19
188
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
84
1.20
0.14
1.5
2.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
96
0.83
0.14
1.6
2.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
109
0.82
0.13
1.0
1.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
116
1127
1.05
0.12
5.3
5.6
e9/l
1.8
1.9
0.54
108
990
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
85
879
0.95
0.11
4.9
4.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
211
2082
1.05
0.11
3.9
4.0
mmol/l
1.3
1.3
0.63
195
1859
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
67
696
0.95
0.10
4.9
4.6
%
24.8
21.3
0.90
33
346
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
85
877
0.96
0.10
4.9
5.2
ug/l
7.5
2.4
0.48
73
760
(3002032) Base excess in Venous blood by calculation
21
228
0.91
0.10
2.2
4.0
mmol/l
2.8
1.9
0.55
16
182
(3022621) pH of Urine by Test strip
15
166
0.90
0.10
4.6
2.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
15
166
0.90
0.10
3.0
2.8
ml/min/173m2
72.4
61.4
—
8
72
(3027315) Oxygen [Partial pressure] in Blood
5
44
1.14
0.10
5.2
2.9
kpa
9.2
8.3
—
5
44
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
45
1.11
0.10
1.4
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
45
1.11
0.10
1.4
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
16
176
0.90
0.09
1.5
2.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
5
47
1.06
0.09
1.2
1.4
mmol/l
69.8
65.1
—
5
42
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
13
116
1.13
0.09
2.2
2.7
%
1.4
1.2
0.70
13
116
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
48
1.04
0.09
1.0
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
113
1105
1.04
0.09
5.3
5.5
e9/l
0.0
0.0
0.64
106
953
(3011397) Hemoglobin [Presence] in Urine by Test strip
51
531
0.95
0.09
4.9
3.8
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
6
56
1.07
0.08
1.5
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
107
1.13
0.08
1.3
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
13
144
0.90
0.08
1.5
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
28
264
1.07
0.08
1.5
1.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
6
72
0.83
0.07
1.2
2.6
mmol/l
20.9
25.5
—
6
59
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
10
112
0.89
0.07
1.3
3.1
u/ml
15.1
41.8
—
10
107
(46235355) HIV 1 and 2 tests - Meaningful Use set
31
326
0.95
0.07
1.5
1.7
—
—
—
0
0
(3020891) Body temperature
8
93
0.86
0.07
4.1
4.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
76
744
1.03
0.05
2.2
2.1
u/l
702.7
229.9
0.64
71
696
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
14
149
0.94
0.03
1.6
1.7
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
26
269
0.96
0.02
4.5
4.2
u/l
304.8
247.5
0.76
26
253
(3001604) Monocytes [#/volume] in Blood
111
1100
1.01
0.02
5.4
5.5
e9/l
0.6
0.6
0.17
104
940
(3005719) IgG [Mass/volume] in Serum or Plasma
16
167
0.96
0.01
2.0
2.7
g/l
8.4
10.8
2.45
16
148
(3021960) Folate [Moles/volume] in Serum or Plasma
60
608
0.98
0.01
1.5
1.5
nmol/l
17.9
20.8
0.76
54
503
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
28
287
0.97
0.01
13.1
7.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
25
244
1.03
0.00
1.8
2.0
ug/g
97.4
144.9
0.63
20
187
(3012544) pH of Venous blood
23
232
0.99
0.00
2.1
4.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
13
131
0.99
0.00
1.0
1.5
g/l
0.6
1.4
2.98
13
121
(3035350) Ketones [Presence] in Urine by Test strip
113
1134
0.99
0.00
4.4
3.8
estimate
0.0
0.0
—
6
221
(21494755) Public health laboratory ask at order entry panel
15
147
1.02
0.00
1.1
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
21
207
1.02
0.00
3.1
3.5
ng/l
96.3
85.7
0.27
21
183
(3019225) pH of Specimen
24
237
1.01
0.00
3.5
4.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
135
1.04
0.00
1.1
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
21
215
0.97
0.00
1.3
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
58
0.86
0.00
1.2
1.2
—
4.1
—
0
7
(3000764) Benzodiazepines [Presence] in Urine
5
58
0.86
0.00
25.4
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
5
58
0.86
0.00
1.2
1.2
—
4.4
—
0
7
(3027008) Opiates [Presence] in Urine
5
58
0.86
0.00
25.4
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
8.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
59
0.84
0.00
26.0
1.4
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
1.8
—
0
6
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
88
0.91
0.00
3.0
1.9
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
7.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
55
0.91
0.00
1.4
3.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
0.3
—
0
6
(3016244) Insulin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
11.3
—
0
7
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
59
1.02
0.00
1.3
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
69
0.87
0.00
1.2
1.7
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
0.00
0.0
1.1
—
128.5
—
0
8
(3048879) Bone marrow aspiration report
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
6.0
—
0
7
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
3.4
—
161.6
—
0
5
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
55
0.91
0.00
4.0
2.1
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
9
0.00
0.00
0.0
4.1
—
54.8
—
0
9
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
76
0.92
0.00
1.7
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
59
1.02
0.00
4.8
1.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
54
0.92
0.00
25.4
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
19
190
1.00
0.00
5.4
3.7
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
29.9
—
0
8
(3013293) Extractable nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
7.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
5
55
0.91
0.00
2.6
2.0
g/l
142.2
127.9
—
5
39
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H8_POSTOP and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_POSTOP | 1.144 [0.98, 1.33] | 0.082 |
| Birth year | 0.996 [0.99, 1.0] | 0.295 |
During the follow-up period (1.1.1998 — 31.12.2019), 277 out of 1246 females with H8_POSTOP died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_POSTOP | 1.039 [0.89, 1.21] | 0.623 |
| Birth year | 0.989 [0.98, 1.0] | 0.021 |
During the follow-up period (1.1.1998 — 31.12.2019), 310 out of 1325 males with H8_POSTOP died.
Mortality risk
Mortality risk for people of age
years, who have H8_POSTOP.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.115% | 0.218% |
| 5 | 0.677% | 1.277% |
| 10 | 1.588% | 3.284% |
| 15 | 3.028% | 6.119% |
| 20 | 5.623% | 10.166% |
Relationships between endpoints
↥Index endpoint: H8_POSTOP – Postprocedural disorders of ear and mastoid process, not elsewhere classified
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data